Molbio Diagnostics Ltd.

•

molbiodiagnostics.comBSE: -NSE: MOLBIO

Market Cap₹ 14,498 Cr.

Current Price

High / Low₹ 1,294 / 926

Stock P/E87.0

Book Value₹ 123

Price to Book12.23

Dividend Yield0.00 %

ROCE19.8 %

ROE15.4 %

Face Value₹ 1

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence

50%

View full sector analysis →

PROS

Operating margins have improved to 22.2% from 13.0%
Company comfortably covers its interest (7.9x coverage)
Company maintains a comfortable, low leverage position

CONS

Equity base is being diluted - shares outstanding up 400.3%
Total debt has risen sharply - up 235.0% year on year
Recurring exceptional / one-off items are inflating headline profit
Though reporting repeated profits, the company pays out little dividend (0.0%)

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcareMedical Equipment/Supplies/Accessories

Part ofNIFTY 50 NIFTY 500 NIFTY LARGEMIDCAP 250 NIFTY 100 NIFTY 200

S.No.	Name
1.	LENSKART	694.05	184.20	120716.54	0.00	2284.30	3634.35	27141.80	1332.69	12.55	21.70
2.	POLYMED	1723.80	55.45	17472.69	0.20	85.27	-8.39	525.38	30.30	14.05	24.11
3.	MOLBIO	1258.10	87.03	14498.34	0.00	527.44	—	4083.76	—	19.79	24.63
4.	3BBLACKBIO	1472.10	22.75	1263.45	0.34	8.98	-28.99	33.49	50.59	26.03	25.45
5.	LAXMIDENTL	200.40	35.70	1102.79	0.00	10.32	23.83	74.70	16.13	24.96	20.26
6.	GKB	66.13	10.28	33.33	0.00	1.85	387.99	33.04	2.26	8.82	7.97

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Jun 2025	Jun 2026
	100	4,084
	131	3,356
Operating Profit	-31	728
OPM %	-31.28%	17.83%
	1	31
Interest	4	107
Depreciation	12	171
Profit before Tax	-31	759
Tax %	23.45%	30.52%
Net Profit	-24	527
	-2.10	5.21

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	332	837	1,020	1,446
	289	602	758	1,124
Operating Profit	43	234	262	321
OPM %	12.98%	27.99%	25.70%	22.23%
	5	-49	-4	9
Interest	7	14	18	33
Depreciation	32	41	45	64
Profit before Tax	10	130	194	231
Tax %	136.11%	35.56%	28.72%	28.99%
Net Profit	-3	84	139	164
EPS	-3.22	452.32	64.32	14.77
Dividend Payout %	0.00%	0.00%	0.00%	0.00%

COMPOUNDED SALES GROWTH

10 Years:: —
5 Years:: —
3 Years:: 63%

COMPOUNDED PROFIT GROWTH

10 Years:: —
5 Years:: —
3 Years:: —

STOCK PRICE CAGR

10 Years:: —
5 Years:: —
3 Years:: —
1 Year:: —

RETURN ON EQUITY

10 Years:: —
5 Years:: —
3 Years:: 14%
Last Year:: 15%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	2	2	2	11
Minority Interest	16	5	-1	139
	719	821	966	1,158
	138	193	154	420
Trade Payables	86	94	230	200
	63	76	63	169
Total Liabilities	1,024	1,192	1,415	2,097
	286	256	290	536
Capital Work in Progress	0	2	27	11
	6	6	46	6
	347	315	436	449
	189	425	272	409
Cash & Bank	7	22	129	367
	189	165	216	318
Total Assets	1,024	1,192	1,415	2,097

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	64	10	287	50
Cash from Investing	-40	-45	-123	-93
Cash from Financing	18	-32	-26	276
	43	-67	138	233

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2023	Mar 2024	Mar 2025	Mar 2026

Shareholding Pattern

Numbers in percentages

	Aug 2026
	41.29
	1.51
	16.36
Government	0.00
	40.82

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-09

Updates

2026-09-09 - Molbio Diagnostics Limited has informed the Exchange regarding Intimation regarding change of Corporate Identification Number (CIN) of the Company.

2026-09-08

Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-08 - Molbio Diagnostics Limited has informed the Exchange about Link of Recording

2026-09-08

General Updates

2026-09-08 - Molbio Diagnostics Limited has informed the Exchange about Investor Presentation on the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2026

2026-09-07

Copy of Newspaper Publication

2026-09-07 - Molbio Diagnostics Limited has informed the Exchange about Copy of Newspaper Publication of Un-audited Financial Results for the quarter ended June 30, 2026.

2026-09-07

Press Release

2026-09-07 - Molbio Diagnostics Limited has informed the Exchange regarding a press release dated September 07, 2026, titled "Press Release for the Quarter ended June 30, 2026.".

2026-09-05

Outcome of Board Meeting

2026-09-05 - Molbio Diagnostics Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

2026-09-02

Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-02 - Molbio Diagnostics Limited has informed the Exchange that an Earnings Conference Call is scheduled on Tuesday, 08th September 2026 at 04.00 P.M. IST to discuss the financial performance of the Company for the quarter ended June 30, 2026.

2026-08-27

Outcome of Board Meeting

2026-08-27 - Molbio Diagnostics Limited has informed the Exchange regarding Outcome of Board Meeting held on August 27, 2026.

2026-08-20

Trading Window

2026-08-20 - Molbio Diagnostics Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

News

Recent coverage and analyst commentary for MOLBIO

Loading news…

🤖

AI Stock Analyst

Molbio Diagnostics Ltd.

🔒

Sign in to Chat with AI

✨ Sign In to Chat

Free 5nance Account

Name

LENSKART

694.05

184.20

120716.54

0.00

2284.30

3634.35

27141.80

1332.69

12.55

21.70

POLYMED

1723.80

55.45

17472.69

0.20

85.27

-8.39

525.38

30.30

14.05

24.11

MOLBIO

1258.10

87.03

14498.34

0.00

527.44

—

4083.76

—

19.79

24.63

3BBLACKBIO

1472.10

22.75

1263.45

0.34

8.98

-28.99

33.49

50.59

26.03

25.45

LAXMIDENTL

200.40

35.70

1102.79

0.00

10.32

23.83

74.70

16.13

24.96

20.26

GKB

66.13

10.28

33.33

0.00

1.85

387.99

33.04

2.26

8.82

7.97

Jun 2025

Jun 2026

100

4,084

131

3,356

Operating Profit

-31

728

OPM %

-31.28%

17.83%

Interest

107

Depreciation

171

Profit before Tax

-31

759

Tax %

23.45%

30.52%

Net Profit

-24

527

-2.10

5.21

Mar 2023

Mar 2024

Mar 2025

Mar 2026

332

837

1,020

1,446

289

602

758

1,124

Operating Profit

234

262

321

OPM %

12.98%

27.99%

25.70%

22.23%

-49

-4

Interest

Depreciation

Profit before Tax

130

194

231

Tax %

136.11%

35.56%

28.72%

28.99%

Net Profit

-3

139

164

EPS

-3.22

452.32

64.32

14.77

Dividend Payout %

0.00%

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Equity Capital

Minority Interest

-1

139

719

821

966

1,158

138

193

154

420

Trade Payables

230

200

169

Total Liabilities

1,024

1,192

1,415

2,097

286

256

290

536

Capital Work in Progress

347

315

436

449

189

425

272

409

Cash & Bank

129

367

189

165

216

318

Total Assets

1,024

1,192

1,415

2,097

Mar 2023

Mar 2024

Mar 2025

Mar 2026

287

Cash from Investing

-40

-45

-123

-93

Cash from Financing

-32

-26

276

-67

138

233

Mar 2023

Mar 2024

Mar 2025

Mar 2026

Aug 2026

41.29

1.51

16.36

Government

0.00

40.82

Molbio Diagnostics Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI

Molbio Diagnostics Ltd.

AI Sector View

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Corporate actions

Cash Flows

Ratios

Shareholding Pattern

Documents

News

Sign in to Chat with AI